Trial · NCT03813238
Results by group88
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 88
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Movement Disorder-Childhood Rating Scale (MD-CRS) Part II Total Score (Movement Disorder Severity, Centrally Read) at Week 15 | Placebo | -0.4 | Standard Error 1.09 | units on a scale | |
| Change From Baseline in the Movement Disorder-Childhood Rating Scale (MD-CRS) Part II Total Score (Movement Disorder Severity, Centrally Read) at Week 15 | TEV-50717 | -1.5 | Standard Error 0.88 | units on a scale | |
| Change From Baseline in the MD-CRS Part I Total Score (General Assessment, Centrally Read) at Week 15 | Placebo | -0.8 | Standard Deviation 2.51 | units on a scale | |
| Change From Baseline in the MD-CRS Part I Total Score (General Assessment, Centrally Read) at Week 15 | TEV-50717 | -0.7 | Standard Deviation 2.10 | units on a scale | |
| Caregiver Global Impression of Improvement (CaGI-I) Scale Score (Global, Caregiver Rated) at Week 15 | Placebo | 3.3 | Standard Deviation 0.83 | units on a scale | |
| Caregiver Global Impression of Improvement (CaGI-I) Scale Score (Global, Caregiver Rated) at Week 15 | TEV-50717 | 3.3 | Standard Deviation 0.84 | units on a scale | |
| Clinical Global Impression of Improvement (CGI-I) Scale Score (Global, Physician Rated) at Week 15 | Placebo | 3.5 | Standard Deviation 0.87 | units on a scale | |
| Clinical Global Impression of Improvement (CGI-I) Scale Score (Global, Physician Rated) at Week 15 | TEV-50717 | 3.4 | Standard Deviation 0.78 | units on a scale | |
| Change From Baseline in Unified Huntington's Disease Rating Scale-Total Maximal Chorea (UHDRS-TMC) Score (Centrally Read) at Week 15 | Placebo | 0.3 | Standard Deviation 2.87 | units on a scale | |
| Change From Baseline in Unified Huntington's Disease Rating Scale-Total Maximal Chorea (UHDRS-TMC) Score (Centrally Read) at Week 15 | TEV-50717 | -1.2 | Standard Deviation 2.52 | units on a scale | |
| Change From Baseline in Unified Huntington's Disease Rating Scale-Total Maximal Dystonia (UHDRS-TMD) Score (Centrally Read) at Week 15 | Placebo | -0.6 | Standard Deviation 1.46 | units on a scale | |
| Change From Baseline in Unified Huntington's Disease Rating Scale-Total Maximal Dystonia (UHDRS-TMD) Score (Centrally Read) at Week 15 | TEV-50717 | -0.2 | Standard Deviation 1.19 | units on a scale | |
| Change From Baseline in the MD-CRS Part I Total Score (General Assessment, Physician Rated) at Week 15 | Placebo | -0.7 | Standard Deviation 3.21 | units on a scale | |
| Change From Baseline in the MD-CRS Part I Total Score (General Assessment, Physician Rated) at Week 15 | TEV-50717 | -1.0 | Standard Deviation 3.57 | units on a scale | |
| Change From Baseline in the MD-CRS Part II Total Score (General Assessment, Physician Rated) at Week 15 | Placebo | -1.5 | Standard Deviation 3.20 | units on a scale | |
| Change From Baseline in the MD-CRS Part II Total Score (General Assessment, Physician Rated) at Week 15 | TEV-50717 | -2.4 | Standard Deviation 3.15 | units on a scale | |
| Change From Baseline in MD-CRS Global Index Score (Calculated From MD-CRS Parts I and II Total Scores, Physician Rated) at Week 15 | Placebo | -0.0 | Standard Deviation 0.06 | units on a scale | |
| Change From Baseline in MD-CRS Global Index Score (Calculated From MD-CRS Parts I and II Total Scores, Physician Rated) at Week 15 | TEV-50717 | -0.0 | Standard Deviation 0.06 | units on a scale | |
| Change From Baseline in MD-CRS Global Index Score (Calculated From MD-CRS Parts I and II Total Scores, Centrally Read) at Week 15 | Placebo | -0.0 | Standard Deviation 0.08 | units on a scale | |
| Change From Baseline in MD-CRS Global Index Score (Calculated From MD-CRS Parts I and II Total Scores, Centrally Read) at Week 15 | TEV-50717 | -0.0 | Standard Deviation 0.06 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03813238/results